Parkinson's UK invests in development of potential new drugs to protect brain cells using mitochondria Date 5 June 2024 We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.
Caption Photo by Aurore Delsoir Photography Prize for work ensuring patient voice is included in research Date 31 May 2024 A partnership involving Parkinson’s UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
Awarding nearly £600,000 to support the next leaders in Parkinson's research Date 11 April 2024 Parkinson’s UK has funded two future leaders in Parkinson’s research who are pushing forward our understanding of the early stages and causes of Parkinson’s.
Gut bacteria transplant may improve Parkinson’s movement symptoms Date 8 April 2024 Early research shows transplanting gut bacteria from healthy individuals to people with Parkinson’s, called a faecal microbiota transplant, is safe and may ease motor symptoms.
Results from a phase 2 trial of lixisenatide have been published Date 4 April 2024 Lixisenatide, a diabetes drug being investigated for Parkinson’s, shows potential to slow the progression of movement symptoms.
New research study shows impact of delirium for people with Parkinson’s in hospital Date 21 March 2024 New research study shows impact of delirium for people with Parkinson’s in hospital
Skin biopsy as a potential method towards a test for Parkinson’s Date 21 March 2024 The simple skin test was able to detect a troublesome protein associated with Parkinson's and other similar conditions.
Parkinson’s UK funds nearly £450,000 for research exploring new ways to manage Parkinson’s symptoms Date 19 March 2024 Our latest round of grants fund projects which aim to improve everyday life for people living with Parkinson’s, without the need for extra medications.
Caption Image: Mint Motion for Passionate Productions An update on GDNF trials for Parkinson’s Date 28 February 2024 A further trial of a device-delivered GDNF is not going ahead, but other approaches are showing promise.
Over 10,000 people helping to understand Parkinson’s risk factors Date 14 February 2024 Predict-PD is a study that aims to understand the risk factors of Parkinson’s. More than 10,000 people are now taking part and are representative of the ethnic diversity within the UK population.
